Brittany Oliver
Dermatology · Washington, DCNPI 1003349317
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $14,850 of the $18,071 with a category attached, or 82.2%. AbbVie accounts for 84.0% of it on its own, with 27 other manufacturers making up the rest. 2025 is the largest year on record at $9,587, more than ten times the $16 reported in 2021.
Across 145 payments — averaging $124.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$15K
- Dermavant Sciences, Inc.$525
- E.r. Squibb & Sons, L.L.C.$400
- Amgen$228
- Sanofi$216
- Lilly USA, LLC$178
- plus $1K from 22 others
What the payments were for
- Consulting fees$14,85082%
- Food & beverage$3,04217%
- Education$1791%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $15,181 |
| Dermavant Sciences, Inc. | 35 | $525 |
| E.r. Squibb & Sons, L.L.C. | 12 | $400 |
| Amgen | 6 | $228 |
| Sanofi | 7 | $216 |
| Lilly USA, LLC | 5 | $178 |
| Sensus Healthcare, Inc. | 1 | $165 |
| Galderma Laboratories, L.p. | 8 | $158 |
| LEO Pharma Inc. | 7 | $154 |
| Incyte Corporation | 5 | $106 |
| Sun Pharmaceutical Industries Inc. | 5 | $93 |
| Almirall LLC | 4 | $89 |
| Convatec Inc. | 4 | $88 |
| Sanofi-aventis U.S. LLC | 1 | $80 |
| Organogenesis Inc. | 3 | $69 |
| Johnson & Johnson | 3 | $62 |
| UCB, Inc. | 3 | $48 |
| Kerecis Limited | 3 | $46 |
| Smith+Nephew | 1 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $23 |
| Novartis | 1 | $20 |
| Nabriva Therapeutics, PLC | 1 | $17 |
| Verrica Pharmaceuticals Inc. | 1 | $17 |
| Arcutis Biotherapeutics, Inc. | 1 | $14 |
| EPI Health, LLC | 1 | $13 |
| Organon | 1 | $10 |
| Mayne Pharma Commercial LLC | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,071 in reported general payments places this provider in the 75th percentile of 73 dermatology providers in District of Columbia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 14 | $51,842 |
| Dupixent SyringeDupilumab | 13 | $47,594 |
| Clobetasol Propionate | 88 | $4,239 |
| Ketoconazole | 122 | $1,870 |
| Fluorouracil | 26 | $1,808 |
| Tacrolimus | 21 | $1,593 |
| Doxycycline Hyclate | 44 | $1,359 |
| Hydroxychloroquine Sulfate | 15 | $1,107 |
| Mycophenolate Mofetil | 14 | $1,025 |
| Triamcinolone Acetonide | 78 | $703 |
| Clindamycin Phosphate | 20 | $576 |
| Finasteride | 44 | $549 |
| MethotrexateMethotrexate Sodium | 24 | $498 |
| Minoxidil | 24 | $243 |
| Spironolactone | 17 | $224 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Washington
- Jonathan SilverbergWashington$4.5M
- Adam FriedmanWashington$2.2M
- Terrence KeaneyWashington$1.1M
- Candrice HeathWashington$168K
- Agnes ChangWashington$109K
- Todd PerkinsWashington$102K
- Karl SaardiWashington$101K
- Noelle SherberWashington$96K
- Yolanda HolmesWashington$80K
- Cheri FreyWashington$79K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.